Psycheceutical Chief Visionary Officer Zappy Zapolin and CEO Chad Harman with MAPS Founder Rick Doblin MIAMI, March 29, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. ("Psycheceutical" or ...
Rick Doblin, Ph.D., founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS) at PS2023. Psychedelic Science 2025 (PS2025) is inviting trauma therapists and other ...
With more than 500 speakers, PS2025 is the largest psychedelic conference in the world — and this year, its Doblin Track (named for MAPS’ visionary founder, Rick Doblin) stands out as one of the most ...
For the first time, Latin America will host a gathering of the world’s leading minds in psychedelics, mental health, and longevity. On October 8–10, Buenos Aires will become the stage for LaPsyConf, a ...
The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the center of psychedelic science and advocacy for nearly four decades. From MDMA-assisted therapy trials to policy reform ...
MIAMI, March 29, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results